Biosimilar Scientific Workshops
Parallel Scientific workshops on Biopharmaceutical Product Development
Listen to industry and academia experts from the field of biopharmaceutical
Established Technologies
Emerging Technologies
Standard Workshops
Agenda
| Day 1: 02/02/2023 11:30-13:00 | Session | Cell Line and Upstream Process Development | Venue: Mobor hall |
|---|---|
| Moderator: Dr. Sanjeev Gupta, Ipca Laboratories Ltd | |
| Speaker | Dr. Sivaprakash Ramalingam, CSIR-IGIB | Cell-line engineering using genome-engineering technologies |
| Dr. Ravi Mishra, CSIR-IMTECH | Emerging Cell Line Engineering technologies and their potential for High Yield Biopharmaceutical Production | |
| Thermo Fisher Representative | |
| Advanced techniques for media and process optimization for biologics manufacturing | Dr. Yaron Silberberg, Ajinomoto Genexine | |
| Perfusion Medium Flexibility and Scale-Down Considerations |Mr. Christopher Brau, Thermo Fisher Scientific | |
| Panel Discussion | Dr. Venkata ramana, Reliance Lifescience |
| Dr. Sunit Maity, Syngene International Limited | |
| Mr. Chistopher Brau | |
| Dr. Yaron Silberg, Ajinomoto | |
| Day 1: 02/02/2023 11:30-13:00 | Session | Protein Aggregation and Biophysical Characterization | Venue: Bethul Hall |
| Moderator: Dr. Navaratna Vajpai, Biocon Biologics Ltd | |
| Speaker | Dr. Ashutosh Kumar, IIT-Bombay | HOS of Biopharmaceuticals in-formulation state by NMR spectroscopy |
| Mr. Pradeep Iyer, Hetero Biopharma | |
| Dr. Vadiraja B. Bhat, Agilent Technologies India | |
| Dr. Dama Venugopal Rao, Dr. Reddy's Ltd | |
| Panel Discussion | Dr. Ravishankara N, Sunpharma |
| Dr. Ashutosh Kumar, IIT-Bombay | |
| Mr. Pradeep Iyer, Hetero Biopharma | |
| Dr. Dama Venugopal Rao, Dr. Reddy's Ltd | |
| Day 1: 02/02/2023 11:30-13:00 | Session | PAT, Data Analytics and Industry 4.0: Next Generation | Venue: Grandball Room |
| Moderator: Dr. Parthasarathy Sampathkumar, Biocon Biologics Ltd | |
| Speaker | Model based Control of Continuous Bioprocesses | Dr. Anurag Rathore, IIT-Delhi |
| Applied biologics development and cGMP manufacturing with focus on transition to Industry 4.0 | Mr. Anshuman Bansal, Factorian | |
| Raman PAT for Upstream Monitoring | Dr. Janice Tan, Merck KGaA | |
| Dr. Manish Khandagale, Perkin Elmer | |
| Panel Discussion | Dr. Anurag Rathore, IIT-Delhi |
| Dr. Manish Khandagale, Perkin Elmer | |
| Mr. Anshuman Bansal, Factorian | |
| Dr. Janice Tan, Merck KGaA | |
| Day 1: 02/02/2023 11:30-13:00 | Session | Protein Aggregation and Biophysical Characterization | Venue: Bethul Hall |
| Moderator: Dr. Navaratna Vajpai, Biocon Biologics Ltd | |
| Speaker | Dr. Ashutosh Kumar, IIT-Bombay | HOS of Biopharmaceuticals in-formulation state by NMR spectroscopy |
| Mr. Pradeep Iyer, Hetero Biopharma | |
| Dr. Dama Venugopal Rao, Dr. Reddy's Ltd | |
| Panel Discussion | Dr. Ravishankara N, Sunpharma |
| Dr. Ashutosh Kumar, IIT-Bombay | |
| Mr. Pradeep Iyer, Hetero Biopharma | |
| Dr. Dama Venugopal Rao, Dr. Reddy's Ltd | |
| Day 1: 02/02/2023 14:30 - 16:00 | Session | Mass Spectroscopy for Protein and Peptide Characterization | Venue: Bethul Hall |
| Moderator: Dr. Annu Uppal, USP | |
| Speaker | Dr.Pramod Wangikar, IIT-Bombay |
| Dr. Vaishali Sinha, Syngene International Ltd | |
| Dr. Diane McCarthy, Senior Director, Global Biologics, US Pharmacopeia | |
| Panel Discussion | Dr. Bhavesh Vats, Lupin |
| Dr.Pramod Wangikar, IIT-Bombay | |
| Dr. Vaishali Sinha, Syngene International Ltd | |
| Dr. Diane McCarthy, Senior Director, Global Biologics, US Pharmacopeia | |
| Day 1: 02/02/2023 14:30 - 16:00 | Session | Advances in Single Use Technology | Venue: Grandball room |
| Moderator: Mr. Om Narayan, Kashiv Biosciences | |
| Speaker | Single use disposable BioSettlers for selective cell retention or primary clarification of CHO cells | Dr. Dhinakar Kompala, Sudhin Biopharma Co. |
| Approaches to intensification of next generation processes utilising single use technologies | Dr. Andreas Castan, Cytiva | |
| Advances in Single Use Technology applied in Biopharmaceuticals | Mr. Sudeep Sen, Thermo Fisher Scientific | |
| Mr. Ravindra Patel, OmniBRx Biotechnologies Pvt Ltd. | |
| Panel Discussion | Dr. Huzaifa Choonia, Stelis Biopharma |
| Mr. Prashant Godse, Lupin | |
| Mr. Sethu Madhavan, Biocon Biologics | |
| Dr. Dhinakar Kompala, Sudhin Biopharma Co | |
| Dr. Andreas Castan, Cytiva | |
| Day 1: 02/02/2023 14:30 - 16:00 | Session | Advances in Purification Technologies | Venue: Mobor Hall |
| Moderator Mr. Gaurav Nagar, Serum Institute of India. | |
| Speaker | Dr. Rahul Bambure, CSIR-NCL |
| Mechanistic modelling for twin column continuous process | Mr. Vinay Pandey, Biocon Biologics Ltd | |
| Mr. Larry Russo, Repligen Company | |
| Scalable, Flexible and Reliable Solutions to Simplify Your m-RNA Production | Mr.Niddivinayak Mishra,Sartorius | |
| Repligen representative | |
| Panel Discussion | Dr. Rahul Bambure, CSIR-NCL |
| Mr. Vinay Pandey, Biocon Biologics Ltd | |
| Mr. Larry Russo, Repligen Company | |
| Ms. Sirat Sikka, Thermo Fisher Scientific | |
| Mr.Niddivinayak Mishra,Sartorius | |
| Day 2: 03/02/2023 08:45-10:45 | Session | FDA Compliance: Meeting regulatory expectations in product development and manufacturing | Venue: Grandball room |
| Moderator: Dr. Dhananjay Patankar, Independent Consultant | |
| Speaker | Regulatory Expectations for Biosimilar Manufacturing | Dr. Sarah McMullen, US-FDA |
| Pre-Approval Inspections for Biosimilars | Dr. Sriram Akundi, Biocon Biologics Ltd | |
| Panel Discussion | Dr. Swapnil Ballal, Q-Exl Partners |
| Dr. Shaligram Rane, Lupin | |
| Dr. Sarah McMullen, US-FDA | |
| Dr. Sriram Akundi, Biocon Biologics Ltd | |
| Day 2: 03/02/2023 08:45-10:45 | Session | Cell-based potency assay -designs and considerations | Venue: Bethul Hall |
| Moderator: Dr. Shubrata Khedkar, USP | |
| Speaker | Dr. Abhishek Mathur, Biolexis Pvt Ltd |
| Dr. Pallavi Karnik, Intas Pharmaceutical | |
| Development of T-cell based bioassays | Dr. Nimesh Gupta, National Institute of Immunology | |
| Surrogate potency assays using Biacore systems | Dr. Shubhendu Seal, Cytiva | |
| Panel Discussion | Dr. Shashwati Basak, Intas Pharmaceutical |
| Dr. Diane McCarthy, Senior Director, Global Biologics, US Pharmacopeia | |
| Dr. Abhishek Mathur, Biolexis Pvt Ltd | |
| Dr. Pallavi Karnik, Intas Pharmaceutical | |
| Day 2: 03/02/2023 08:45-10:45 | Session | Formulation Technologies and Excipients-Protein Interaction | Venue: Mabor Hall |
| Moderator : Dr. Sachin Dubey, KBI Biopharma | |
| Speaker | Vaccine development: improving stability to enable global access | Dr. Martinus Capelle, Johnson and Johnson |
| Dr. Nupur Mehrota, Premas Biotech | |
| The viscosity reduction platform: Enabling subcutaneous (subQ) delivery | Dr. Smita Rajput | |
| Panel Discussion | Dr. Ajay Singh, Gennova Biopharmaceuticals |
| Dr. Rajendra Burki, Biological -E Ltd | |
| Dr. Martinus Capelle | |
| Dr. Nupur Mehorora | |
| Day 2: 03/02/2023 14:15- 16:15 | Session | Challenges in clinical trials for cell and gene therapies | Venue: Grandball room |
| Moderator: Dr. Gaurav Narula, Tata Memorial Hospital | |
| Speaker | Dr. Stephan Grupp, Children's Hospital of Philadelphia |
| Dr. Akshay Sharma, St. Jude Children's Hospital | |
| Dr. Alok Srivastava, Christian Medical College | |
| Panel Discussion | Dr. Nikita Mehra, Cancer Institute (WIA) |
| Dr. Hasmukh Jain, Tata Memorial Hospital | |
| Dr. Sattva Neelapu, University of Texas, MD Anderson Cancer Centre | |
| Dr. Stephan Grupp, Children's Hospital of Philadelphia | |
| Dr. Akshay Sharma, St. Jude Children's Hospital | |
| Dr. Alok Srivastava, Christian Medical College | |
| Day 2: 03/02/2023 14:15- 16:15 | Session | Challenges and Opportunities in MSAT | Venue: Bethul Hall |
| Moderator: Mr. Vivek Farkade, BSV | |
| Speaker | CPV challenges and approach: MSAT perspective | Mr. Mayank Garg, Biocon Biologics Ltd |
| Criticality of MSAT in Evolving CDMO space | Dr. Mohan Kumar, Syngene International Ltd | |
| Panel Discussion | Dr. Prateek Gupta, Stelis Biopharma |
| Independent consultant | Dr. Narahari Rao, | |
| Mr. Mayank Garg, Biocon Biologics Ltd | |
| Dr. Mohan Kumar, Syngene International Ltd | |
| Day 2: 03/02/2023 14:15- 16:15 | Session | Special Guidance session by DCGI and RCGM on Biosimilars/Vaccine product approval | Venue: Mobor Hall |
| Moderator: Dr. Swapnil Ballal, Q-exl Partners | |
| Chair: Dr. Nitin Jain, RCGM ( DBT-representative) | |
| Guest: Dr. YK Gupta, Director AIIMS-Bhopal | |
If you wish to participate as an attendee then click the link and register now!